{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:40:10Z","timestamp":1756320010303,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Autoimmune blistering diseases are rare but potentially life-threatening conditions. Pemphigus foliaceus is one of these conditions, characterised by superficial erosions of the skin without mucosal involvement. We report the case of a 57-year-old woman who presented with a 4-week history of rash affecting her scalp with associated hair loss. Clinical and histopathological findings were in keeping with pemphigus foliaceus. She was successfully treated with rituximab, a chimeric monoclonal antibody against CD20, leading to a transient depletion of B cells. After 5\u2009months of follow-up, her rash had cleared, and her hair had completely regrown.<\/jats:p>","DOI":"10.1136\/bcr-2018-229026","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T06:35:16Z","timestamp":1559198116000},"page":"e229026","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Refractory pemphigus foliaceous treated with rituximab"],"prefix":"10.1136","volume":"12","author":[{"given":"Fatima","family":"Awdeh","sequence":"first","affiliation":[{"name":"Dermatology, Tallaght Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eimear","family":"Gilhooley","sequence":"additional","affiliation":[{"name":"Dermatology, Tallaght Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"O Grady","sequence":"additional","affiliation":[{"name":"Dermatology, Tallaght Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Connolly","sequence":"additional","affiliation":[{"name":"Dermatology, Tallaght Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"2025082711180303000_12.5.e229026.1","doi-asserted-by":"crossref","unstructured":"Murrell DF , Pe\u00f1a S , Joly P , et al . Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol 2018:30207\u2013X.doi:10.1016\/j.jaad.2018.02.021","DOI":"10.1016\/j.jaad.2018.02.021"},{"key":"2025082711180303000_12.5.e229026.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00033.x"},{"key":"2025082711180303000_12.5.e229026.3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12772"},{"key":"2025082711180303000_12.5.e229026.4","unstructured":"Jenson KK . Treatment of refractory pemphigus foliacues with rituximab. Practical Dermatology 2016."},{"key":"2025082711180303000_12.5.e229026.5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00105-008-1682-0","article-title":"of pemphigus foliaceus with rituximab","volume":"60","author":"Alter","year":"2009","journal-title":"Hautarzt"},{"key":"2025082711180303000_12.5.e229026.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28547"},{"key":"2025082711180303000_12.5.e229026.7","first-page":"449","volume-title":"Dermatology","volume":"Vol 1","author":"Amagai","year":"2003"},{"key":"2025082711180303000_12.5.e229026.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.01.013"},{"key":"2025082711180303000_12.5.e229026.9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.det.2011.03.012","article-title":"Diagnosis and clinical features of pemphigus foliaceus","volume":"29","author":"James","year":"2011","journal-title":"Dermatol Clin"},{"key":"2025082711180303000_12.5.e229026.10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025082711180303000_12.5.e229026.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.014"},{"key":"2025082711180303000_12.5.e229026.12","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"2025082711180303000_12.5.e229026.13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamadermatol.2014.2421","article-title":"First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids","volume":"151","author":"Ingen-Housz-Oro","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2025082711180303000_12.5.e229026.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.016"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-229026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:18:11Z","timestamp":1756318691000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-229026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,29]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bcr-2018-229026"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-229026","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}